| Market Cap | ₹2,404Cr |
| ROE | -11.28% |
| P/E Ratio(TTM) | -20.84 |
| EPS(TTM) | -12.50 |
| P/B Ratio | 2.45 |
| Dividend Yield | 0.08% |
| Industry P/E | 33.57 |
| Book Value | 106.21 |
| Debt to Equity | 1.02 |
| Face Value | 2 |
| Parent Organisation | Indoco Remedies Limited |
| Managing Director | Mr. Sundeep Bambolkar |
| NSE Symbol | INDOCO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 82.27 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.89 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.53 | ||
| Wockhardt | NA (0.00%) | -426.40 |